Document is current

Any future updates will be listed below

685 A first-in-human Phase 1/2 clinical trial of SIRPα<sup>low</sup> activated macrophages (SIRPant-M) for the treatment of R/R-NHL

Crossref DOI link: https://doi.org/10.1136/jitc-2023-SITC2023.0685

Published Online: 2023-11-02

Published Print: 2023-11

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark